Dogs can 'smell' bladder cancer

September 23, 2004

Dogs can be trained to detect bladder cancer by 'smelling' urine, concludes new research published in this week's BMJ.

Tumours are thought to produce volatile organic compounds with distinctive odours. Even when present in minute quantities, it is possible that they are detectable by dogs, with their exceptional sense of smell.

The study involved urine samples from 36 patients with bladder cancer and 108 control samples from diseased (non-cancerous) and healthy individuals; 63 of the samples were used exclusively in final testing of the dogs.

Six dogs of varying breeds and ages were trained over 7 months to discriminate between urine from patients with bladder cancer and that from control individuals.

For the final tests, each dog was offered a set of seven urine samples, comprising one bladder cancer sample and six sex-matched controls. Some controls were also age-matched and most had some form of non-malignant urological disorder. The dogs identified their chosen sample by lying next to it. Each dog performed a total of 9 separate tests.

Taken together as a group, the dogs correctly selected bladder cancer urine on 22 out of 54 occasions, an average success rate of 41% compared to 14% expected by chance alone. The dogs' capacity to recognise a characteristic bladder cancer odour was independent of other chemical aspects of the urine, such as the presence of blood.

"Our study provides the first piece of experimental evidence to show that dogs can detect cancer by olfactory means more successfully than would be expected by chance alone," say the authors.

"The results we achieved should provide a benchmark against which future studies can be compared, and it is to be hoped that our approach to training may assist others engaged in similar work."

"The study was carefully designed to include several features to minimise bias, and it is hard to fault the study in this respect," writes an expert in medical statistics in an accompanying commentary. "On balance the results are unambiguous. Dogs can be trained to recognise and flag an unusual smell in the urine of bladder cancer patients."
-end-


BMJ

Related Bladder Cancer Articles from Brightsurf:

Effectiveness of gemcitabine & daily RT for bladder preservation in muscle-invasive bladder cancer
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for selected patients with muscle-invasive bladder cancer.

Anthrax may be the next tool in the fight against bladder cancer
Researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors.

Effectiveness of a new bladder cancer treatment demonstrated
Demonstrated the effectiveness of a drug for treating metastatic bladder cancer in patients who did not respond to the usual treatment.

Lifting the lid on bladder cancer support
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to talk about, with many becoming homebound as they cope with debilitating side effects such as incontinence.

How genomics profiling can help identify the best treatment for bladder cancer
A new computational tool -- a single-patient classifier -- effectively enables physicians to assign a bladder cancer subtype to an individual patient's cancer using that patient's genomic data.

Early menopause in smokers linked to bladder cancer
Research shows that experiencing menopause before the age of 45 is associated with a higher risk of bladder cancer.

Olfactory receptor as therapeutic target in bladder cancer
Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.

Bladder cancer model could pave the way for better drug efficacy studies
In the journal Cancer Research, UNC Lineberger Comprehensive Cancer Center researchers report they have developed a model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer.

Genetic fixer-uppers may help predict bladder cancer prognosis
Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers, who found that bladder cancer patients who had mutations in their ATM or RB1 genes -- proteins that help repair DNA damage when they're functioning normally -- tended not to live as long as patients without the mutations.

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer
Researchers from Mount Sinai and Sema4, a health information company and Mount Sinai venture, have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumors have certain genetic mutations may respond particularly well to this combination approach, according to the results of a clinical trial published in European Urology.

Read More: Bladder Cancer News and Bladder Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.